ENTITY
Novartis India

Novartis India (HCBA IN)

4
Analysis
Health CareIndia
Novartis India Limited manufactures pharmaceuticals and animal healthcare products to protect health, cure disease and improve well-being. The Company sells prescription drugs as well as generic and OTC medicines. Novartis is currently organized into three divisions: Pharmaceuticals, Sandoz - which comprises of their activities in generic prescription drugs and Consumer Health.
more
15 Oct 2024 11:20

Rubicon Research Pre-IPO - Robust Product Development Pipeline Driving Revenue Growth

Rubicon Research Limited is looking to raise about US$130m in its India IPO. In this note, we talk about the company’s historical performance.

Logo
271 Views
Share
08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Share
22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Logo
4.9k Views
Share
01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective:  2014 Actual...

Share
No more insights
x